c_Jun (Ab_239) Antibody
- Known as:
- c_Jun (Ab_239) Antibody
- Catalog number:
- E021024-2
- Product Quantity:
- 100ug
- Category:
- Antibodies
- Supplier:
- EnoGene
- Gene target:
- c_Jun (Ab_239) Antibody
Related products to: c_Jun (Ab_239) Antibody
Related articles to: c_Jun (Ab_239) Antibody
- Forensic psychiatric patients experience high rates of preventable physical illness. Integrating primary care within forensic settings may help address this gap, yet little is known about how patients experience such services. - Source: PubMed
Publication date: 2026/06/13
Terkildsen Morten DeleuranJentz ChristianKennedy HarrySandbæk AnnelliAndersen AnetteUhrskov Sørensen Lisbeth - Follicular lymphoma (FL) is an indolent lymphoma characterized by repeated relapses and progressively shorter responses with successive lines of therapy, particularly in patients with early progression (POD24). Although chemoimmunotherapy has historically dominated treatment, the therapeutic landscape has shifted toward chemo-free approaches. T-cell - redirecting therapies, including bispecific antibodies, have demonstrated high efficacy in relapsed/refractory (R/R) FL. - Source: PubMed
Publication date: 2026/06/13
Garcia-Sancho Alejandro MartínCabero-Martínez AlmudenaGutierrez Norma C - Background The limits of viability, commonly defined by gestational age and/or birth weight thresholds associated with a survival probability exceeding 50 %, have evolved with advances in neonatal care. However, these thresholds vary substantially across countries, reflecting differences in health system capacity rather than fixed biological boundaries. ContentThis review critically examines the definition of the limits of viability as a context-dependent construct shaped by access to perinatal and neonatal care. It analyzes global disparities in survival at the margins of prematurity, with marked differences between high-income (HIC) and low- and middle-income countries (LMIC). These inequities are discussed within the framework of the Sustainable Development Goals (SDG), particularly SDG 3 and SDG 10, and in relation to the child's right to the highest attainable standard of health. The role of global health governance, including the World Health Organization (WHO), and emerging challenges affecting international collaboration are also considered. Current trends in both HIC and LMIC are evaluated to assess alignment between technological progress and global health equity.SummaryThe limits of viability are not fixed biological thresholds but reflect health system capacity. Persistent disparities in periviable survival remain substantial and result in outcomes determined largely by place of birth rather than biological potential.OutlookReducing inequities requires prioritizing equitable implementation of evidence-based interventions, strengthening health systems, and sustaining global collaboration. Aligning advances in neonatal care with global equity is essential to improving outcomes for the most vulnerable newborns. - Source: PubMed
Publication date: 2026/06/10
Stanojević MilanKociszewska-Najman BożenaDomański Andrzej - Trofinetide (TROF) remains the first and only FDA-approved pharmacologic treatment for Rett syndrome (RTT). There is limited real-world evidence on TROF use, restarts, dosing patterns and predictors of non-persistence. This study evaluated long-term treatment patterns and baseline predictors of non-persistence among RTT individuals initiating TROF. - Source: PubMed
Publication date: 2026/06/13
Rashid NaziaYakkala Vinod KumarSyed Safiuddin ShoebRajagopalan Krithika - Noise is a widespread harmful environmental stressor that burdens large urban populations globally. Exposure to environmental noise at elevated levels increases annoyance and disturbance, posing substantial risks to both mental and physical health. While the dangers of noise exposure have been widely recognized, the quantitative relationship between noise exposure and psychological response is not well translated to the environmental noise community. This study attempts to estimate people's annoyance generated by exhaust ventilation noise in a residential community through field measurements and theoretical exposure modeling. The sound pressure levels (SPLs) were sampled at multiple points first, and then a double-layer sound insulation strategy was implemented to reduce the noise levels. Acoustic computations show that the percentage of highly annoyed population in building A before and after duct-borne noise treatment were 11.6% 9.8%, demonstrating reasonable alleviation of noise annoyance and voluntary compliance with the WHO health-based guidelines. Moreover, issues in current environmental noise regulations and their implementation were pointed out, offering suggestions for potential improvements in local legislation. Finally, the methodology and recommendations presented in this study can assist environmental health professionals and policymakers in their efforts to alleviate noise annoyance and develop informative noise control guidelines in the future. - Source: PubMed
Publication date: 2026/06/13
Chen KangShi Jing